Literature DB >> 19811952

Oxidative stress in bone remodelling and disease.

Fabien Wauquier1, Laurent Leotoing, Véronique Coxam, Jérôme Guicheux, Yohann Wittrant.   

Abstract

Oxidative stress is characterised by an increased level of reactive oxygen species (ROS) that disrupts the intracellular reduction-oxidation (redox) balance. Although initially shown to be involved in aging, physiological roles for ROS in regulating cell functions and mediating intracellular signals have emerged. In bone tissues, recent studies have demonstrated that ROS generation is a key modulator of bone cell function and that oxidative status influences the pathophysiology of mineralised tissues. Here, we review the crucial role of oxidative stress in bone pathophysiology, and discuss the possibility that ROS production might be a relevant therapeutic target under certain conditions. Further studies will be needed to investigate whether manipulation of the redox balance in bone cells represents a useful approach in the design of future therapies for bone diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811952     DOI: 10.1016/j.molmed.2009.08.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  138 in total

1.  Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice.

Authors:  Ganesh V Halade; Amina El Jamali; Paul J Williams; Roberto J Fajardo; Gabriel Fernandes
Journal:  Exp Gerontol       Date:  2010-10-12       Impact factor: 4.032

2.  Effects of Tanshinone IIA on osteogenic differentiation of mouse bone marrow mesenchymal stem cells.

Authors:  Kejun Qian; Huazhong Xu; Teng Dai; Keqing Shi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-01       Impact factor: 3.000

3.  Favorable effect of dietary vitamin C on bone mineral density in postmenopausal women (KNHANES IV, 2009): discrepancies regarding skeletal sites, age, and vitamin D status.

Authors:  Y A Kim; K M Kim; S Lim; S H Choi; J H Moon; J H Kim; S W Kim; H C Jang; C S Shin
Journal:  Osteoporos Int       Date:  2015-04-24       Impact factor: 4.507

4.  Nox2 Activity Is Required in Obesity-Mediated Alteration of Bone Remodeling.

Authors:  Md Mizanur Rahman; Amina El Jamali; Ganesh V Halade; Allal Ouhtit; Haissam Abou-Saleh; Gianfranco Pintus
Journal:  Oxid Med Cell Longev       Date:  2018-11-08       Impact factor: 6.543

5.  Serum uric acid is associated with quantitative ultrasound parameters in men: data from the Camargo cohort.

Authors:  J L Hernández; D Nan; J Martínez; E Pariente; I Sierra; J González-Macías; J M Olmos
Journal:  Osteoporos Int       Date:  2015-03-03       Impact factor: 4.507

6.  Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.

Authors:  Bo Ma; Qi Zhang; Di Wu; Yong-lu Wang; Ying-ying Hu; Yan-ping Cheng; Zhen-dong Yang; Ya-ya Zheng; Han-Jie Ying
Journal:  Acta Pharmacol Sin       Date:  2012-03-19       Impact factor: 6.150

Review 7.  Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics.

Authors:  Susmita Bose; Gary Fielding; Solaiman Tarafder; Amit Bandyopadhyay
Journal:  Trends Biotechnol       Date:  2013-09-06       Impact factor: 19.536

Review 8.  The Role of Bone Marrow Microenvironment in Governing the Balance between Osteoblastogenesis and Adipogenesis.

Authors:  Jiao Li; Xingyu Liu; Bin Zuo; Li Zhang
Journal:  Aging Dis       Date:  2015-12-06       Impact factor: 6.745

9.  The role of oxidative stress in aseptic loosening of total hip arthroplasties.

Authors:  Marla J Steinbeck; Lauren J Jablonowski; Javad Parvizi; Theresa A Freeman
Journal:  J Arthroplasty       Date:  2013-11-26       Impact factor: 4.757

10.  Higher serum uric acid is associated with higher lumbar spine bone mineral density in male health-screening examinees: a cross-sectional study.

Authors:  Jiwon Hwang; Jung Hye Hwang; Seungho Ryu; Joong Kyong Ahn
Journal:  J Bone Miner Metab       Date:  2018-01-25       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.